These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1096799)

  • 21. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.
    Pogwizd SM; Lerner SA
    Antimicrob Agents Chemother; 1976 Dec; 10(6):878-84. PubMed ID: 795373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.
    Tsang JC; Sansing GA; Miller MA
    Antimicrob Agents Chemother; 1975 Sep; 8(3):277-81. PubMed ID: 1101819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and epidemiologic study of multiresistant Serratia marcescens infections in a spinal cord injury rehabilitation unit.
    Simor AE; Ramage L; Wilcox L; Bull SB; Bialkowska-Hobrzanska H
    Infect Control; 1988 Jan; 9(1):20-7. PubMed ID: 3276639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serratia marcescens as a postoperative pathogen.
    Williams TW; Sailer JE; Viroslav J; Knight V; Glasgow N; Moreland N
    Am J Surg; 1971 Jul; 122(1):64-9. PubMed ID: 4326385
    [No Abstract]   [Full Text] [Related]  

  • 26. Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa.
    Olexy VM; Bird TJ; Grieble HG; Farrand SK
    Antimicrob Agents Chemother; 1979 Jan; 15(1):93-100. PubMed ID: 106772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killing of Serratia marcescens biofilms with chloramphenicol.
    Ray C; Shenoy AT; Orihuela CJ; González-Juarbe N
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):19. PubMed ID: 28356113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone resistance in clinical isolates of Serratia marcescens.
    Fujimaki K; Fujii T; Aoyama H; Sato K; Inoue Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 May; 33(5):785-7. PubMed ID: 2546493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serratia: a problem in a neonatal nursery.
    Fitzgerald P; Drew JH; Kruszelnicki I
    Aust Paediatr J; 1984 Aug; 20(3):205-7. PubMed ID: 6391456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid-determined resistance to fosfomycin in Serratia marcescens.
    Mendoza C; Garcia JM; Llaneza J; Mendez FJ; Hardisson C; Ortiz JM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):215-9. PubMed ID: 7004337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance of the genera Proteus, Providencia and Serratia with special reference to multiple resistance patterns.
    von Graevenitz A; Nourbakhsh M
    Med Microbiol Immunol; 1972; 157(2):142-8. PubMed ID: 4554514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them].
    Kolganov AN; Vakulenko SB
    Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.
    Traub WH; Raymond EA
    Appl Microbiol; 1972 Jan; 23(1):4-7. PubMed ID: 4621796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity studies on Serratia strains from clinical specimens.
    von Graevenitz A
    Chemotherapy; 1967; 12(4):215-25. PubMed ID: 4863818
    [No Abstract]   [Full Text] [Related]  

  • 37. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.
    Sifuentes-Osornio J; Ruiz-Palacios GM; Gröschel DH
    J Clin Microbiol; 1986 Feb; 23(2):230-4. PubMed ID: 3517048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial susceptibility of enterobacteriaceae isolated from raw horsemeat isolated for human consumption (basashi).
    Furuhata K; Ishizaki N; Fukuyama M
    Biocontrol Sci; 2015; 20(1):19-25. PubMed ID: 25817809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.